Edition:
United States

ALK-Abello A/S (ALKb.CO)

ALKb.CO on Copenhagen Stock Exchange

732.00DKK
10:59am EST
Change (% chg)

kr.7.00 (+0.97%)
Prev Close
kr.725.00
Open
kr.727.00
Day's High
kr.732.00
Day's Low
kr.719.00
Volume
27,310
Avg. Vol
17,022
52-wk High
kr.1,133.00
52-wk Low
kr.681.00

Summary

Name Age Since Current Position

Steen Riisgaard

66 2012 Independent Chairman of the Board

Carsten Hellmann

53 2017 President, Chief Executive Officer

Lene Skole

57 2015 Vice Chairman of the Board

Flemming Pedersen

52 Chief Financial Officer, Executive Vice President

Henrik Jacobi

52 Executive Vice President, Research and Development

Soeren Niegel

46 2017 Executive Vice President, Commercial Operations and Product Supply

Katja Barnkob Thalund

48 2011 Director, Employee Representative

Lars Holmqvist

58 2015 Director

Jacob Kastrup

56 2011 Director, Employee Representative

Andreas Slyngborg Holst

64 2015 Director, Employee Representative

Per Valstorp

68 2015 Director

Anders Gersel Pedersen

65 2005 Independent Director

Jakob Riis

50 2013 Independent Director

Per Plotnikof

Vice President Corporate Communications, Investor Relations and Strategic Planning

Biographies

Name Description

Steen Riisgaard

Mr. Steen Riisgaard has been Independent Chairman of the Board of Directors at Alk-Abello A/S since March 27, 2012. He also serves as Chairman of the Company’s Remuneration and Nomination Committees. He joined the Board as Independent Member in 2011. He has experience in management and board work as well as experience in research and development and sales and marketing in international companies. He is Chairman of the Boards of Directors of COWI Holding A/S, Xellia Pharmaceutical A/S, WWF Danmark and Egmont International Holding A/S. He is also Vice Chairman of The Novo Nordisk Foundation and The Villum Foundation, as well as Member of the Boards of Novo A/S, VKR Holding A/S, Carbion N.V. and Aarhus University.

Carsten Hellmann

Mr. Carsten Hellmann has been appointed President and Chief Executive Officer at Alk-Abello A/S effective as of January 1, 2017. He has been CEO of Merial and Executive Vice President and member of the Executive Committee of Sanofi. Before joining Sanofi, Carsten Hellmann held executive positions in global health care and biopharmaceutical companies including Chr. Hansen and Nunc Group.

Lene Skole

Ms. Lene Skole has been Vice Chairman of the Board of Directors of Alk-Abello A/S since March 12, 2015. She has been Member of the Board since March 12, 2014. She is Chief Executive Officer of The Lundbeck Foundation. She has experience, financial and economic knowledge and skills in strategy and communication in international companies. She has is Vice Chairman of the Board of Dong Energy A/S, Falck A/S and H. Lundbeck A/S as well as Member of the Board of Tryg Forsikring A/S.

Flemming Pedersen

Mr. Flemming Pedersen no longer serves as Chief Financial Officer and Executive Vice President at Alk-Abello A/S effective as of by January 2, 2018. He is also Member of the Board of Directors of Goodstream A/S.

Henrik Jacobi

Soeren Niegel

Mr. Soeren Daniel Niegel has served as Executive Vice President, Commercial Operations and Product Supply at Alk-Abello A/S since November 29, 2017. He has previously been Executive Vice President, Commercial Operations at Alk-Abello A/S. He joined the Company on August 1, 2012.

Katja Barnkob Thalund

Ms. Katja Barnkob Thalund has been Employee Representative on the Board of Directors at Alk-Abello A/S since 2011. She is Senior CMC Project Manager at the Company.

Lars Holmqvist

Mr. Lars Holmqvist has been Director of ALK-Abello A/S since March 12, 2015. He was previously Independent Member of the Board of Directors of ALK-Abello A/S from 2010 until March 12, 2013. He is also Member of the Company’s Remuneration Committee. Previously, he was Independent Vice Chairman of the Board of the Company between April 1, 2011 and March 27, 2012. Mr. Holmqvist is Member of the Board of BPL Holdings, UK; H. Lundbeck A/S; Tecan AG, Switzerland and Lundbeckfonden. He has experience in management, finance, sales and marketing in international life science companies, including med-tech and pharmaceutical companies.

Jacob Kastrup

Mr. Jacob Kastrup has been Employee Representative on the Board of Directors at Alk-Abello A/S since 2011. He is Facility Manager at the Company.

Andreas Slyngborg Holst

Mr. Andreas Slyngborg Holst has been Director, Employee Representative at Alk-Abello A/S since 2015. He is EU QPPV Director of Pharmacovigilance Support at the Company.

Per Valstorp

Mr. Per Valstorp has been Member of the Board of Director of Alk-Abello A/S since March 12, 2015. He is also Member of the Audit Committee. He has considerable experience in global production within the pharmaceutical industry and other sectors. He is also Chairman of Orana A/S and Member of the Boards of DBI Plastics A/S, European Freeze Dry ApS, New Xellia Group A/S and Scanbur A/S.

Anders Gersel Pedersen

Dr. Anders Gersel Pedersen, M.D., Ph.D. has been Independent Member of the Board of Directors of Alk-Abello A/S since 2005. He also serves as Member of the Company’s Remuneration Committee and Chairman of the Scientific Committee. He has experience in management, innovation and research and development in the international pharmaceutical industry. Mr. Gersel Pedersen is Executive Vice President at H. Lundbeck A/S. Apart from that, he is Vice Chairman of the Boards of Directors of Genmab A/S and Bavarian Nordic A/S.

Jakob Riis

Mr. Jakob Riis has served as Independent Member of the Board of Directors of Alk-Abello A/S since March 12, 2013. He also serves as Executive Vice President at Novo Nordisk A/S. He is Chairman of the Audit Committee of the Company. He has experience in management, sales and marketing in the international pharmaceutical industry. He is Chairman of Copenhagen Institute of Interaction Design.

Per Plotnikof